SRSF1

Serine/arginine-rich splicing factor 1 · Q07955 · SRSF1 on Sugi Atlas →

0 patent compounds predicted against SRSF1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SRSF1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer PHASE2COMPLETED
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI PHASE1/PHASE2UNKNOWN
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia PHASE2ACTIVE_NOT_RECRUITING
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer PHASE1/PHASE2COMPLETED
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Research for Individualized Therapeutics in Rare Genetic Disease nanENROLLING_BY_INVITATION
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes nanCOMPLETED
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients nanCOMPLETED
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SRSF1 binder may also engage these)

ProteinNameSimilarity
Q0VCY7 1.000 Q0VCY7 →
Q5R7H2 1.000 Q5R7H2 →
Q3YLA6 1.000 Q3YLA6 →
Q6NYA0 1.000 Q6NYA0 →
Q6DII2 1.000 Q6DII2 →
Q6PDM2 1.000 Q6PDM2 →
Q7SXP4 1.000 Q7SXP4 →
Q9D0B0 0.999 Q9D0B0 →
Q5PPI1 0.998 Q5PPI1 →
Q9NEW6 0.998 Q9NEW6 →
O22315 0.996 O22315 →
A2RVS6 0.995 A2RVS6 →
Q9ZPX8 0.994 Q9ZPX8 →
F4JHI7 0.992 F4JHI7 →
SRSF9 Serine/arginine-rich splicing factor 9 0.992 landscape →
Q23120 0.991 Q23120 →
Q6K4N0 0.988 Q6K4N0 →
P92965 0.987 P92965 →
P92964 0.986 P92964 →
Q9XFR5 0.986 Q9XFR5 →
O81126 0.985 O81126 →
Q9SJA6 0.985 Q9SJA6 →
P78814 0.985 P78814 →
Q8VYA5 0.985 Q8VYA5 →
SRSF2 Serine/arginine-rich splicing factor 2 0.984 landscape →
Q69KL9 0.984 Q69KL9 →
Q06A98 0.984 Q06A98 →
Q3MHR5 0.983 Q3MHR5 →
Q6PDU1 0.983 Q6PDU1 →
Q09511 0.983 Q09511 →